Compagnie du (CBDG) | Financial Analysis & Statements
Compagnie du Cambodge | Large-cap | Financial Services
Compagnie du Cambodge | Large-cap | Financial Services
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
31.3M
Gross Profit
-3.4M
-10.86%
Operating Income
2.4M
7.67%
Net Income
45.7M
146.01%
EPS (Diluted)
€0.70
Balance Sheet Metrics
Total Assets
7.5B
Total Liabilities
117.9M
Shareholders Equity
7.4B
Debt to Equity
0.02
Cash Flow Metrics
Operating Cash Flow
6.8M
Free Cash Flow
-2.5M
Revenue & Profitability Trend
Compagnie du Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 31.3M | 200.0K | 200.0K | 200.0K | 200.0K |
| Cost of Goods Sold | 34.7M | 1.4M | 1.1M | 1.5M | 1.6M |
| Gross Profit | -3.4M | -1.2M | -900.0K | -1.3M | -1.4M |
| Operating Expenses | 200.0K | 0 | 0 | 0 | 2.3M |
| Operating Income | 2.4M | -1.2M | -900.0K | -900.0K | -1.3M |
| Pre-tax Income | 55.9M | 42.1M | 14.1M | 6.9M | 22.7M |
| Income Tax | 10.2M | 8.6M | 2.2M | 2.8M | 3.8M |
| Net Income | 45.7M | 33.3M | 11.8M | 18.9M | 15.9M |
| EPS (Diluted) | €0.70 | €0.55 | €0.20 | €22.90 | €29.80 |
Income Statement Trend
Compagnie du Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 1.7B | 907.2M | 1.0B | 1.2B | 1.3B |
| Non-Current Assets | 5.8B | 3.7B | 3.5B | 3.3B | 2.2B |
| Total Assets | 7.5B | 4.6B | 4.5B | 4.5B | 3.6B |
| Liabilities | |||||
| Current Liabilities | 107.4M | 8.7M | 2.1M | 4.0M | 89.8M |
| Non-Current Liabilities | 10.5M | 7.4M | 5.1M | 7.6M | 11.3M |
| Total Liabilities | 117.9M | 16.1M | 7.2M | 11.6M | 101.1M |
| Equity | |||||
| Total Shareholders Equity | 7.4B | 4.6B | 4.5B | 4.5B | 3.5B |
Balance Sheet Composition
Compagnie du Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 40.3M | 31.0M | 11.3M | 3.4M | 17.6M |
| Operating Cash Flow | 6.8M | -400.0K | 8.1M | 2.5M | -1.3M |
| Investing Activities | |||||
| Capital Expenditures | -100.0K | 0 | - | - | -7.1M |
| Investing Cash Flow | 685.2M | 0 | -7.2M | 1.0M | -7.2M |
| Financing Activities | |||||
| Dividends Paid | -100.7M | -100.8M | -100.8M | -100.8M | -100.8M |
| Financing Cash Flow | -63.2M | -69.1M | -96.3M | -96.0M | -93.6M |
| Free Cash Flow | -2.5M | 12.6M | 11.8M | 3.5M | 4.3M |
Cash Flow Trend
Compagnie du Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
150.00
Price to Book
1.18
Price to Sales
203.66
PEG Ratio
5.68
Profitability Ratios
Profit Margin
128.75%
Operating Margin
-9.94%
Return on Equity
0.76%
Return on Assets
-0.04%
Financial Health
Current Ratio
15.36
Debt to Equity
0.73
Beta
0.44
Per Share Data
EPS (TTM)
€0.70
Book Value per Share
€88.61
Revenue per Share
€0.55
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| cbdg | 6.4B | 150.00 | 1.18 | 0.76% | 128.75% | 0.73 |
| Covivio S.A | 5.7B | 81.59 | 0.69 | 1.65% | 6.09% | 90.76 |
| Pluxee NV | 2.7B | 16.24 | 8.46 | 69.29% | 13.10% | 305.61 |
| Carmila S.A | 2.3B | 7.51 | 0.69 | 9.36% | 59.74% | 80.62 |
| Medincell S.A | 565.5M | -18.81 | - | 61.33% | -66.50% | -1.44 |
| Valneva SE | 409.5M | 70.64 | 2.11 | -44.11% | -43.21% | 120.48 |
Financial data is updated regularly. All figures are in the company's reporting currency.